1. 10/7/2016 BioScience has $50M for biotechs
http://www.news.com.au/finance/business/breakingnews/biosciencehas50mforbiotechs/newsstory/62cb0f1fa294be7752feae4542841af5 1/3
breaking news
BioScience has $50M for biotechs
Newsbites Finance
Melbourne healthcare investment specialist BioScience Managers has reported
two initiatives aimed at funding early stage and commercialising biotech
companies.
The company has set up the $50 million BioScience Managers Ventures I Fund, the
first of a planned series of funds, designed for significant investor visa applicants
which be offered as a venture capital opportunity exclusively to clients of listed fund
manager BT Investment Management.
Bioscience has also has applied to participate in the federal governments $250
million Biomedical Translational Fund (BTF).
Managing director Jeremy Curnock Cook said small healthcare and biomedical
companies were particularly suitable for venture capital investment because of the
size of the opportunity and the high potential returns.
You need high returns to match the higher risk but with judicious selection, there is
no reason why investors should not do very well out of this sort of investment, he
said.
Chief investment officer Matt McNamara, said the Ventures 1 Fund would use the
strategy that has produced annualised net returns above 20 per cent for several
previous funds.
Our approach is always to be hands on with management and to take a relatively
large stake in a smaller number of investments to ensure we can contribute, to make
a significant difference, Mr McNamara said.
He said BioScience would continue to comb through more than 200 investment
opportunities each year, choosing only those that are high quality and have
significant technological or market advantages.
Once they are identified, we remain closely involved in helping to commercialise
these innovative discoveries.
178
READERS
Heritagelisted Sydney landmark sold
to Chinese billionaires
89
READERS
Bank inquiry: What Big Four Banks
couldn’t answer
88
READERS
IMF warns against economic
protectionism
70
READERS
Domino’s Fairy Meadow sued over
pizza delivery
RIGHT NOW IN FINANCE
FROM OUR NETWORK
Hipages Fox Sports Seek Carsguide RealEstate News Network
National World Lifestyle Travel Entertainment Technology Finance Sport Video
Aldi slashes
spring prices
Dick Smith CEO
finally has his day
in court
Bank boss says
complaints
difficult
Iconic Sydney
landmark sold to
Chinese
billionaires
business
OCTOBER 5, 2016 5:49PM
Cuoco’s red carpet debut
with new love
CELEBRITY LIFE
Caitlyn’s shock gaffe after
Kim attack
CELEBRITY LIFE
LATEST IN FINANCE
Advertisement
2. 10/7/2016 BioScience has $50M for biotechs
http://www.news.com.au/finance/business/breakingnews/biosciencehas50mforbiotechs/newsstory/62cb0f1fa294be7752feae4542841af5 2/3
The companies in this fund will be at an earlier stage than our other funds, so we will
help them to meet the challenges of developing management teams, adding
regulatory and clinical trial expertise and being introduced to capital and
international networks.
Successful BTF fund management applicants will need to privately raise funds that at
least match the federal governments initial $250 million investment. The BTF aims
to expand Australias innovative biomedical and healthcare sector by investing up to
$500 million in companies undertaking significant clinical trials and
commercialisation activities.
Victorias minister for Small Business, Innovation and Trade, Philip Dalidakis,
welcomed the Ventures 1 Fund.
Victoria is already home to over 40 per cent of Australias ASX Life sciences
companies, with a startup sector that is growing faster than anywhere else in the
country.
BioScience Managers is a leading healthcare investment specialist founded in 2003,
with the help of VicStart. It invests in a portfolio of biomedical companies which
have clear technological and market advantages in which it can influence success and
is confident of managing an exit. Jeremy Curnock Cook is an industry veteran with
more than 30 years of experience in healthcare investing
Significant investor visas allow applicants access to a permanent Australian visa if
they invest at least $5 million into complying significant investments for a minimum
of four years.
BT Investment Management is one of the largest ASX-listed pure investment
managers with a market capitalisation of around $2.7 billion and funds under
management of $79.7 billion.
PROMOTED STORIES
08:52 Oil hits 4month highs
08:46 Copper hits twoweek low as dollar gains
08:38 Gold hits lowest in four months
07:40 Finance News Update, what you need t…
07:38 US soda group suspends dietitian pay…
AUS/ASIA USA EUROPEAN AUD/USD OIL
EXCHANGE POINTS CHANGE PERCENT
EXCHANGE POINTS CHANGE PERCENT
Hang Seng 23952.5 +164.19 +0.69
ASX200 5483.0 +30.1 +0.55
All Ords 5564.8 +27.8 +0.5
Nikkei 16899.1 +79.86 +0.47
FINANCE BREAKING NEWS
WORLD MARKETS
Tips to help you pop the question this spring
SPONSORED CONTENT
GQ provides tips on how, when and where to propose this spring to help you pop the question
in the most seasonal way possible.
NBN
3…2…1… lift off!
Australia's second
broadband satellite
launches
AGL
How did AGL make the
solar Smart Plan so smart?
AGL
Now you can have a mini
power station on your roof.
AGL
The city of the future is
solar. Guess which cities
are leading?
AGL
If you DIY, make sure you
do it right
ESUPERFUND
3 reasons to use your super
to buy property
REALESTATE.COM.AU
Australia's emerging
supertowns
GETCOURSE
Top 3 Reasons People Hire
Graphic Designers - VET
FEE-HELP 35+ Courses |
Study Now Pay Later
The ultimate fun park for
adults!
Analysis of ASX
Performance for the
What $28 million men
couldn’t answer
FINANCE
STOCK QUOTES
(http://www.ratecity.com.au)
Extra low interest rate
No upfront or ongoing
fees
Go To Site
Value Offer 20% Deposit
Minimum
Today's Deal
3.64
comparison rate
%
Australian Credit License 316710. See our disclosures & comparison warning
Advertisement
Enter company code Search
